• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (23)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Cardiovascular System  • Cardiovascular Disease/ Myocardial Infarction  • Hematology/ Hematologic Malignancies  • Leukemias/ Lymphomas  • Immunology  • Immunologic Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

David Saadoun, MD; Jérémie Sellam, MD; Pascale Ghillani-Dalbin, MD; Richard Crecel, PhD; Jean-Charles Piette, MD; Patrice Cacoub, MD

Arch Intern Med. 2006;166:2101-2108.

Background  Data on essential mixed cryoglobulinemia (MC) are scarce, and most date back to studies before 1989 (ie, before the discovery of hepatitis C virus [HCV] infection). Our objective was to describe the spectrum of MC in the era of HCV infection.

Methods  Retrospective study from a single university hospital's database of 1434 patients who tested positive for MC between January 1989 and December 2003.

Results  One hundred thirty-three patients (9%) with persistent MC without HCV were included in the study. Sixty-five of 133 patients who fulfilled the criteria for MC vasculitis were compared with 118 patients with HCV-related MC vasculitis. The patients without HCV had increased frequencies of renal involvement and B-cell non-Hodgkin lymphoma (NHL), lower gammaglobulin levels, and higher death rates. Twenty-three of the patients had B-cell NHL (primarily of the lymphoplasmocytic and marginal zone types), and 8 patients had Sjögren syndrome. In multivariate analysis, a cryoglobulin level higher than 0.6 g/L (odds ratio [OR], 1.44) and the presence of MC vasculitis (OR, 4.3) and hypogammaglobulinemia (OR, 6.7) were independently associated with B-cell NHL. After a mean follow-up of 49.4 months, 18 (14%) of 133 patients had died, primarily of sepsis. In multivariate analysis, age at diagnosis older than 60 years (OR, 1.06) and renal involvement (OR, 5.20) were independently associated with death.

Conclusion  Patients with non–HCV-related MC vasculitis have a poor outcome and have a 4-fold increased risk of developing B-cell NHL.

Author Affiliations: Departments of Internal Medicine (Drs Saadoun, Sellam, Piette, and Cacoub) and Immunochemistry (Dr Ghillani-Dalbin) and Centre National de la Recherche Scientifique Unité Mixte de Recherche 7087 (Drs Saadoun and Cacoub), Hôpital La Pitié-Salpêtrière; and International Scoring Systems (Dr Crecel); Paris, France.

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Clinical Spectrum, Treatment, and Outcome of Patients with Type II Mixed Cryoglobulinemia without Evidence of Hepatitis C Infection
FOESSEL et al.
The Journal of Rheumatology 2011;38:716-722.
ABSTRACT | FULL TEXT  

Cryoglobulinaemia and rapidly deteriorating renal function in chronic lymphocytic leukaemia
Purhonen et al.
Nephrol Dial Transplant 2011;26:1101-1103.
ABSTRACT | FULL TEXT  

Surrogate markers of B cell non-Hodgkin's lymphoma in patients with hepatitis C virus-related cryoglobulinaemia vasculitis
Geri et al.
Ann Rheum Dis 2010;69:2177-2180.
ABSTRACT | FULL TEXT  

Rituximab plus Peg-interferon-{alpha}/ribavirin compared with Peg-interferon-{alpha}/ribavirin in hepatitis C-related mixed cryoglobulinemia
Saadoun et al.
Blood 2010;116:326-334.
ABSTRACT | FULL TEXT  

An interesting rash: leucocytoclastic vasculitis with type 2 cryoglobulinaemia.
Mannu
J R Soc Med Sh Rep 2010;1:54-54.
FULL TEXT